Kelly France Boothe

A scientist who likes communications better but still a nerd at heart. Currently communicating at @aegleabio & geeking out with @sigpwned. Tweets are my own.

[Aeglea BioTherapeutics @aegleabio]

Last week the Aeglea team celebrated the progress we've made in our mission to change the lives of patients with #rare metabolic diseases. Thanks Danae' and Liz for joining us to share your stories about living with Homocystinuria. You inspire us to work hard each and every day.

[Aeglea BioTherapeutics @aegleabio]

Yesterday was our 5 year anniversary as a public company and we are thrilled to mark the occasion with @nasdaq's Times Square billboard. We're proud of all we've accomplished in the last 5 years and looking forward to what is yet to come for Team Aeglea!

[Kelly France Boothe @KellyF5]

Proud to be part of this team of amazing women who live cool lives and do inspiring work!

[Aeglea BioTherapeutics @aegleabio]

The women of Aeglea rise to the challenge on #InternationalWomensDay and every day in our work to develop life-changing treatments for people living with rare disease. This amazing collection of women are working to change the world! #ChooseToChallenge #IWD2021

[Kelly France Boothe @KellyF5]

So excited to launch our new brand!

[Aeglea BioTherapeutics @aegleabio]

Every day we work to advance our human enzyme therapies with the potential to help families living with #rare metabolic diseases. We've launched a new corporate brand and website that showcases our science and dedicated team. Check out our new look! https://t.co/E2cqN7EY1x

[Aeglea BioTherapeutics @aegleabio]

Is your family impacted by Arginase 1 Deficiency? We'd like to understand the impact of ARG1-D on you and your loved ones. You can share your experiences with us through this short survey: https://t.co/DJ4U5d12id

[Eric Topol @EricTopol]

My open letter to @SteveFDA
https://t.co/LWhPWH3PpS @Medscape

[Aeglea BioTherapeutics @aegleabio]

Yesterday, we virtually presented new 1-year data from our open-label extension study in Arginase 1 Deficiency as a late-breaker at @EANeurology's 6th Congress. You can read about the results here: https://t.co/RxNB68VtFR

[Aeglea BioTherapeutics @aegleabio]

Today we announced that the UK's MHRA approved our Clinical Trial Application for our Homocystinuria program. Read more here: https://t.co/qGV2B1b99L

[Aeglea BioTherapeutics @aegleabio]

Despite the challenges we face with COVID-19, we remain steadfast in our commitment to work as hard and as fast as we can to safely deliver new treatment options for patients. Read more from our CEO Anthony Quinn: https://t.co/7AR2rQ2ZaG

[Kelly France Boothe @KellyF5]

Great article on why we can't gloss over history and to remember that even science is not immune to biases. Want to do better science? Admit you’re not objective https://t.co/T5KsBnaWBY

[Kelly France Boothe @KellyF5]

Congratulations to @W2OGroup CEO, Jim Weiss, @WeissWord, for his new role as Advisory Board Member for the @HBAnet. Learn about his new role & why he’s passionate about furthering the advancement of women’s careers in #healthcare. https://t.co/QxfNEJ728t

[Kelly France Boothe @KellyF5]

As #healthcare leaders assess their strategic capability, #analytics embody a Zen experience to comprehend the business reality. Read more from @W2OGroup President, @JennGottlieb. https://t.co/w5nyC7irdz

[Kelly France Boothe @KellyF5]

Going to #JPM19? @statnews' latest podcast episode is a must listen! @W2OGroup's @MikeHuckman lends his years of JPM expertise to share the most common communications mistakes and clichés you can avoid at the world’s biggest #healthcare investor... https://t.co/qBBI96sQYP

[Kelly France Boothe @KellyF5]

From the DNA of @W2OGroup to women in healthcare, our people discussed it all. Check out some of our favorite blog content from 2018. https://t.co/lG2975WjQh

[Kelly France Boothe @KellyF5]

.@W2OGroup is starting off 2019 with a bang! @PRWeekUS named us one of the Best Places to Work! This is truly a reflection of our incredible team and fantastic clients. #WhyW2O https://t.co/jSTSgSl9yW

[Kelly France Boothe @KellyF5]

Congrats to @W2OGroup CEO, Jim Weiss, @WeissWord, for being named a #HealthInfluencer50 for the third time. Kim Hunter, Founder of The LAGRANT Foundation, shares what makes Jim a visionary leader. https://t.co/F1KGFlPbar

[Kelly France Boothe @KellyF5]

Congrats to President of W2O wcg, Angela Gillespie, @ag_medtech, for being selected to serve on the Global Executive Board of @HBAnet! @W2OGroup https://t.co/zLEvp9jcpj

[Kelly France Boothe @KellyF5]

Proud of you honey! - Congrats to @W2Ogroup’s Head of Data Science, Andy Boothe (@sigpwned), for being recognized as an #Innovator25 by The Holmes Report! @holmesreport https://t.co/RbHoDeSWuF

[Kelly France Boothe @KellyF5]

@CancerResearch has been pioneering immunotherapy to treat cancer for 65 years. CEO Jill O’Donnell-Tormey discusses future of #oncology research, CRI Awards Gala & what it’s like working w/ a Nobel Prize winner on @W2OGroup's #What2Know. #client https://t.co/8noy8zghyT

[Kelly France Boothe @KellyF5]

Very proud of my company, @W2OGroup, to be named as a finalist for @MMMnews’ Large Healthcare Agency of the Year. Kudos to our incredible clients and colleagues for helping to achieve this milestone. #WhyW2O #MMMAwards https://t.co/R6ODGuZgLc